10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $283,000 | -6.9% | 9,948 | +148.7% | 0.01% | -18.2% |
| Q1 2022 | $304,000 | -35.5% | 4,000 | +26.5% | 0.01% | -45.0% |
| Q4 2021 | $471,000 | +79.8% | 3,162 | +136.5% | 0.02% | +150.0% |
| Q2 2021 | $262,000 | -64.4% | 1,337 | -74.3% | 0.01% | -52.9% |
| Q4 2020 | $736,000 | -20.3% | 5,200 | -29.7% | 0.02% | -10.5% |
| Q3 2020 | $923,000 | +158.5% | 7,400 | +85.0% | 0.02% | +137.5% |
| Q2 2020 | $357,000 | +20.2% | 4,000 | +2.7% | 0.01% | +300.0% |
| Q4 2019 | $297,000 | – | 3,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |